The Aperio Blog
Begin With the End in Mind: Are You Ready for First-in-Human Clinical Trials?
You’ve been moving steadily from discovery into preclinical, and based on the data, your molecule will be advancing into First-in-Human clinical trials. But with funds limited, resources tight and many conflicting priorities, how do you know where to begin to make sure your organization is ready for clinical trials?
Watch our presentation moderated by Aperio COO Suzanne Kincaid along with her distinguished line-up of panelists from Nuventra Pharma Sciences, SpringWorks Therapeutics and G1 Therapeutics to learn what your organization needs to do to prepare for First-in-Human.
About Aperio Clinical Outcomes
Aperio Clinical Outcomes provides full, customizable clinical research services across multiple therapeutic areas. Dedicated to transparent interactions with clients, Aperio also offers consulting services in Quality Assurance, Strategic Resourcing, and practical application of the latest Clinical Trial Technology.
In an industry flooded with data, metrics and technology, Aperio remains steadfastly focused on the most important part of the process: people. From start-up to close out and every point in between, Aperio works with its partners to deliver outcomes that will improve patient care and save lives.
Aperio Clinical Outcomes.
We make it clear.
